By conjugating a nucleolin‐specific aptamer with NAMPT PROTAC and a fluorouridine nucleotide, the smart prodrug AS‐2F‐NP demonstrated superior tumor targeting, efficient cellular uptake, improved in vivo potency, and reduced toxicity, thereby providing a promising strategy for the precise delivery of PROTAC and synergistic antitumor agents. Here, NUCLEOLIN is linked to neoplasm.